Congo vs Guinea-Bissau: The number of people with susceptibility test result for rifampicin
Congo
2,015
in 2021
Guinea-Bissau
1,934
in 2021
Congo rank
47th
Guinea-Bissau rank
48th
The number of people with susceptibility test result for rifampicin over time
- Congo
- Guinea-Bissau
How they compare
Congo currently reports 2,015 against 1,934 in Guinea-Bissau, a difference of 81.
Across all 5 years both countries report, Congo has been ahead every year.
Congo ranks 47th and Guinea-Bissau ranks 48th of 155 countries.
Congo has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Congo | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 621 | 20.67 | 600.33 | Congo |
| 2020s | 3,055 | 1,573 | 1,482 | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Congo or Guinea-Bissau?
- Congo, at 2,015 against 1,934 in Guinea-Bissau as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Congo and Guinea-Bissau?
- 81, with Congo ahead.
- How many years of comparable data are there for Congo and Guinea-Bissau?
- 5 years are reported by both, from 2017 to 2021.
- How do Congo and Guinea-Bissau rank globally for the number of people with susceptibility test result for rifampicin?
- Congo ranks 47th and Guinea-Bissau ranks 48th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.